A recent news report came across my desktop the other day giving a new insight to current technological developments in health.
The issue: Newer medical technology is being sent overseas before being able to be perchased in America (regardless of whether or not it was developed in America or not).
The reason: Because the FDA’s regulations for medical products use makes marketing new innovations in America more difficult and perhaps are unnecessary all together. Europe has been more willing to purchase and fund such innovations and has made the medical market turn to them first.
Now this information is still tentative because it was taken in regards to a Northwester University survey, and in many cases surveys are biased and therefore must be taken with a grain of salt (any survey can be worded to make a desirable outcome). However, the fact that this survey was even taken is interesting and brings up a very interesting question about whether our FDA’s regulations are necessary and if it’s jeopardizing our medical field in America when there could be a more innovative way. I’d love to hear more in depth info as to why this may (or may not) be happening. But, I was only able to find this little bit of information.
Full article found here: http://www.therepublic.com/view/story/MED-FDA_5196994/MED-FDA_5196994/
Here is a video I found that explains things a bit further.